United Kingdom

UK's Apollo Therapeutics completes Series C with additional €30.5M
Apollo Therapeutics, a biopharmaceutical company, has successfully concluded its Series C financing with a second close, securing an additional $33.5 million (approximately €30.52 million).
Klarytee, a UK-based cybersecurity startup founded by an immigrant entrepreneur, has successfully raised £700,000 in a pre-seed funding round. This early-stage startup, which integrates security directly into data, has garnered support from notable figures in the tech industry, including former Twitter CISO Michael Coates and former Group CEO of Bupa,

The best Articles in our Network

Previous
Next